Literature DB >> 11311246

Increased alpha3-fucosylation of alpha(1)-acid glycoprotein in patients with congenital disorder of glycosylation type IA (CDG-Ia).

W Van Dijk1, C Koeleman, B Van het Hof, D Poland, C Jakobs, J Jaeken.   

Abstract

Increased fucosylation of the type (sialyl) Lewis(x) was detected on the acute-phase plasma protein alpha(1)-acid glycoprotein (AGP) in patients with the congenital disorder of glycosylation type IA. This is remarkable, because in these patients the biosynthesis of guanosine 5'-diphosphate (GDP)-D-mannose is strongly decreased, and GDP-D-mannose is the direct precursor for GDP-L-fucose, the substrate for fucosyltransferases. The concomitantly occurring increased branching of the glycans of AGP and the increased fucosyltransferase activity in plasma suggest that a chronic hepatic inflammatory reaction has induced the increase in fucosylation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11311246     DOI: 10.1016/s0014-5793(01)02349-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  6 in total

1.  Congenital disorders of glycosylation type I leads to altered processing of N-linked glycans, as well as underglycosylation.

Authors:  P Mills; K Mills; P Clayton; A Johnson; D Whitehouse; B Winchester
Journal:  Biochem J       Date:  2001-10-15       Impact factor: 3.857

2.  Komrower Lecture. Congenital disorders of glycosylation (CDG): it's all in it!

Authors:  J Jaeken
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

Review 3.  Immunological aspects of congenital disorders of glycosylation (CDG): a review.

Authors:  Maria Monticelli; Tiago Ferro; Jaak Jaeken; Vanessa Dos Reis Ferreira; Paula A Videira
Journal:  J Inherit Metab Dis       Date:  2016-07-08       Impact factor: 4.750

Review 4.  Title: Human Serum/Plasma Glycoprotein Analysis by 1H-NMR, an Emerging Method of Inflammatory Assessment.

Authors:  Rocío Fuertes-Martín; Xavier Correig; Joan-Carles Vallvé; Núria Amigó
Journal:  J Clin Med       Date:  2020-01-27       Impact factor: 4.241

5.  Development of a novel system for mass spectrometric analysis of cancer-associated fucosylation in plasma α1-acid glycoprotein.

Authors:  Takayuki Asao; Shin Yazawa; Toyo Nishimura; Takashi Hayashi; Hideyuki Shimaoka; Abby R Saniabadi; Hiroyuki Kuwano
Journal:  Biomed Res Int       Date:  2013-02-13       Impact factor: 3.411

6.  Synaptic roles for phosphomannomutase type 2 in a new Drosophila congenital disorder of glycosylation disease model.

Authors:  William M Parkinson; Michelle Dookwah; Mary Lynn Dear; Cheryl L Gatto; Kazuhiro Aoki; Michael Tiemeyer; Kendal Broadie
Journal:  Dis Model Mech       Date:  2016-03-03       Impact factor: 5.758

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.